Lehrstuhl für Innere Medizin I (Medizin 1)

The transcription factor NFATc3 promotes intestinal inflammation by suppression of regulatory T cells (2017) Gerlach K, Popp V, Neurath M, Weigmann B Conference contribution PREVALENCE AND CHARACTERISTICS OF SPONDYLOARTHRITIS ACCORDING TO ASAS CRITERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - RESULTS FROM THE SPICE COHORT (2017) Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Zimmermann J, Faustini F, Simon D, et al. Conference contribution Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity (2017) Knieling F, Neufert C, Hartmann A, Claussen J, Urich A, Egger C, Vetter M, et al. Journal article, Letter Multispectral Optoacoustic Tomography in Crohn's disease - A First-in-human Diagnostic Clinical Trial (2017) Knieling F, Hartmann A, Uter W, Urich A, Claussen J, Atreya R, Rascher W, Waldner M Conference contribution Multispectral Optoacoustic Tomography in Ulcerative Colitis - A First-in-human Diagnostic Clinical Trial (2017) Knieling F, Hartmann A, Claussen J, Urich A, Atreya R, Rascher W, Waldner M Conference contribution Molecular Imaging of alpha 4 beta 7 Integrin Expression by Confocal Laser Endomicroscopy With Fluorescent Vedolizumab in Crohn's Disease (2017) Rath T, Bojarski C, Neurath M, Atreya R Conference contribution Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors (2017) Doerffel Y, Kullmann F, Lammert F, Quietzsch D, Schöfl C, Schuppert F, Weber M, et al. Conference contribution Effects of different isocaloric oral nutrient solutions on olfactory functioning, hunger and food craving (2017) Thürauf N, Denzer-Lippmann M, Bachlechner S, Wielopolski J, Fischer M, Büttner A, Dörfler A, et al. Conference contribution IL-10 induction properties of the TLR-9 agonist cobitolimod - a candidate for treatment of active ulcerative colitis in late stage of clinical development (2017) Admyre C, Zargari A, Atreya R, Knittel T Conference contribution Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study (2017) Hoersch D, Raderer M, Lahner H, Rinke A, Denecke T, Koch A, Raspel A, et al. Conference contribution